Marina Wolfson is listed as an executive officer on 5 SEC Form D filings by 1 issuer between Oct 2021 and Jan 2026: BiomX Inc. (Ness Ziona, Israel (as filed: L3) — pharmaceuticals — 2021–2026; $61.5M reported sold to 34 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Alan Moses (5 shared filings), Jonathan Solomon (5 shared filings), Merav Bassan (5 shared filings), Russell Greig (5 shared filings), Lynne Sullivan (3 shared filings) and 12 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Marina. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 5 public filings for Marina Wolfson and found 4 differences: Form D filed 17 days after the first sale; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.